---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-239512"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2022-09-07T23:59:59+00:00"
generated_at: "2026-06-23T14:32:16.790866+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Candel Therapeutics names new CFO and CMO; CFO Canepa resigns effective Sept 21

## Summary
- CFO John Canepa resigned effective Sept 21, 2022, to pursue other interests.
- Jason Amello appointed CFO effective Sept 21, 2022; base salary $460K, target bonus 40%.
- Garrett Nichols, MD, MS, appointed CMO effective Sept 12, 2022.
- Amello brings experience from Saniona, Akebia, Genzyme; Nichols from Istari, GSK.

## SEC filing metadata
- accession: 0001193125-22-239512
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2022-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/0001193125-22-239512-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/d352591d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-239512
- JSON: https://secwatch.observer/filing/0001193125-22-239512.json
- Plain text: https://secwatch.observer/filing/0001193125-22-239512.txt

## Key facts
- Executive change
  John Canepa resigned as Chief Financial Officer at Candel Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On September 6, 2022, Candel Therapeutics, Inc. (the “Company”) accepted the resignation of John Canepa as the Company’s Chief Financial Officer, effective September 21, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/0001193125-22-239512-index.htm
- Executive change
  Jason Amello was appointed as Chief Financial Officer at Candel Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Jason Amello as the Company’s Chief Financial Officer, effective September 21, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/0001193125-22-239512-index.htm
- Executive change
  Garrett Nichols was appointed as Chief Medical Officer at Candel Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: appointed Garrett Nichols. M.D., M.S., as the Company’s Chief Medical Officer, effective September 12, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/0001193125-22-239512-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.